Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 Dec 14:4:32-38.
doi: 10.1016/j.toxrep.2016.12.003. eCollection 2017.

Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite

Affiliations

Low-dose dose-response for reduced cell viability after exposure of human keratinocyte (HEK001) cells to arsenite

Kenneth T Bogen et al. Toxicol Rep. .

Abstract

The in vitro arsenite (AsIII) cytotoxicity dose-response (DR) of human keratinocytes (HEK001) was examined at greater statistical resolution than ever previously reported using the MTT assay to determine cell viability. Fifty-four 96-well plates were treated with AsIII concentrations of 0.25, 0.5, 1, 2, 3, 4, 5, 7, 10, 15, 20, 25, or 30 μM. Because of unexpected variation in viability response patterns, a two-stage DR analysis was used in which data on plate-specific viability (%), estimated as 100% times the ratio of measured viability in exposed to unexposed cells, were fit initially to a generalized lognormal response function positing that HEK001 cells studied consisted of: a proportion P of relatively highly sensitive (HS) cells, a proportion Po of relatively resistant cells, and a remaining (1-P-Po) fraction of typical-sensitivity (TS) cells exhibiting the intermediate level of AsIII sensitivity characteristic of most cells in each assay. The estimated fractions P and Po were used to adjust data from all 54 plates (and from the 28 plates yielding the best fits) to reflect the condition that P = Po = 0 to provide detailed DR analysis specifically for TS cells. Four DR models fit to the combined adjusted data were each very predictive (R2 > 0.97) overall but were inconsistent with at least one of the data set examined (p < 10-5). Adjusted mean responses at ≤3 μM were approximately equal (p > 0.30) and exceeded 100% significance (p ≤ 10-6). A low-dose hormetic model provided the best fit to the combined adjusted data for TS cells (R2 = 0.995). Marked variability in estimates of P (the proportion of apparent HS cells) was unexpected, not readily explained, and warrants further study using additional cell lines and assay methods, and in vivo.

Keywords: Arsenate; Arsenic; Cell culture; Cell death; Cytotoxicity; HEK001 cells.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Observed viability data (open points) and corresponding LNS-model fit (dashed curve) for plate #4, compared to data values (solid points) that are all adjusted to reflect this fitted model with assumed parameter values of P = Po = 0 (solid curve).
Fig. 2
Fig. 2
Model fits to adjusted viability data from all 54 plates (top plot), and from 28 plates for which the LNS model yielded fits (to corresponding unadjusted data sets) that are all relatively predictive (R2 ≥ 0.91) and have relatively steep initial slopes (b ≥ 2—see Table 1) (bottom plot). Error bars denote ±1 SEM. Fitted models shown in each plot are: lognormal (dashed curve), cubic-hormetic (solid curve), and cubic (dotted curve, which nearly coincides with the dashed and solid curve at C ≤ 3 μM and C ≥ 4 μM, respectively).

Similar articles

Cited by

References

    1. IARC . Some Drinking-Water Disinfectants and Contaminants, Including Arsenic. International Agency for Research on Cancer (IARC), World Health Organization; France: 2004. IARC monographs on the evaluation of carcinogenic risks to humans. - PMC - PubMed
    1. Chiou J.M., Wang S.-L., Chen C.-J., Deng Lin C.-R.W., Tai T.-Y. Arsenic ingestion and increased microvascular disease risk: observations from the south-western arseniasis-endemic area in Taiwan. Int. J. Epidemiol. 2005;343:936–943. - PubMed
    1. Maull E.A., Ahsan H., Edwards J., Longnecker M.P., Navas-Acien A., Pi J., Silbergeld E.K., Styblo M., Tseng C.-H., Thayer K.A., Loomis D. Evaluation of the association between arsenic and diabetes: a National Toxicology Program workshop review. Environ. Health Perspect. 2012;120:1658–1670. - PMC - PubMed
    1. Naujokas M.F., Anderson B., Ahsan H., Aposhian H.V., Graziano J.H., Thompson C., Suk W.A. The broad scope of health effects from chronic arsenic exposure: update on a worldwide public health problem. Environ. Health Perspect. 2013;121:295–302. - PMC - PubMed
    1. Abernathy C.O., Chappell W.R., Meek M.E., Gibb H. Guo H-R. Is ingested inorganic arsenic a threshold carcinogen. Fundam. Appl. Toxicol. 1996;29:168–175. - PubMed

LinkOut - more resources